Boothbay Fund Management’s Tenax Therapeutics TENX Stock Holding History
Bought
Maintained
Sold
Other funds holding TENX
Boothbay Fund Management's TENX Position: Q3 2026 in Review
Boothbay Fund Management reduced its Tenax Therapeutics (TENX) stake by 91% in Q3 2026, selling an estimated $2.14M and leaving 27,464 shares worth $51.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1852.
Boothbay Fund Management first reported a position in TENX in Q3 2021 and has held it in 8 quarters since. The position peaked at $5.86M in Q1 2026. 106 funds tracked by Wall St. Rank hold TENX as of Q3 2026.
- Boothbay Fund Management held 27,464 shares of Tenax Therapeutics worth $51.9K as of Q3 2026.
- Boothbay Fund Management sold 283,623 Tenax Therapeutics shares in Q3 2026, an estimated $2.14M.
- Tenax Therapeutics made up ﹤0.01% of Boothbay Fund Management's portfolio in Q3 2026, its #1852 holding.
- Boothbay Fund Management first reported a position in Tenax Therapeutics in Q3 2021 and has held it in 8 quarters since.
- Boothbay Fund Management's Tenax Therapeutics position peaked at $5.86M in Q1 2026.
- 106 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.